TheFiscalFinder
● Single award · contract

Clinical Development of CRISPR-CAS3 Phage Cocktail for the Treatment of Recurrent Urinary Tract Infections…

A single federal award, with both ends of the trail linked.
$73.9M
total award value
2020
action date
75 mo
period
75A50120C00169
PIID
Agency ›
Department of Health and Human Services
✓ from source
awarded→$73.9M
State ›
North Carolina
✓ from source

Description

Clinical Development of CRISPR-CAS3 Phage Cocktail for the Treatment of Recurrent Urinary Tract Infections Caused by Escherichia Coli Including Antimicrobial and Multi-Drug Resistant Strains

Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceNorth Carolina →
CategoryNAICS 541714PSC AN13
Competed?Not recorded✓ from source
Total (exact)$73,885,104

More from Department of Health and Human Services

Medicaid Entitlement for 7 - Fy 2026 - T19
awarded 2024$100.1B
Medicaid Entitlement for 7 - Fy 2025 - T19
awarded 2023$92B
Medicaid Entitlement for 7 - Fy 2024 - T19
awarded 2022$80.5B
Medicaid Entitlement for 7 - Fy 2023 - T19
awarded 2021$80.5B
Medicaid Entitlement for 7 - Fy 2022 Quarter 4 - T19
awarded 2022$71.7B
All awards from this agency →
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.